Blood test may unlock faster POTS diagnosis
NCT ID NCT03218761
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to validate a blood test that measures NET mRNA levels as a simpler way to assess norepinephrine transporter function in people with Postural Tachycardia Syndrome (POTS). Researchers will compare these levels with traditional measures in 200 participants, including those with POTS and healthy controls. If the test works, it could make diagnosing POTS easier and faster.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a simpler blood test to help diagnose POTS, replacing older, more complex methods.
- What could go wrong
- This is an early validation study, not a treatment trial. The blood test may not correlate well with actual NET function, limiting its diagnostic value.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTURAL TACHYCARDIA SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Vanderbilt University Medical Center
Nashville, Tennessee, 37232, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could ear nerve stimulation calm racing hearts in POTS?
- Can CO2 calm POTS? small study investigates
- Could antibodies be behind POTS? new study investigates
- Could POTS be an autoimmune disease? new study tests nerve stimulation as a treatment
- Could a blood pressure pill calm racing hearts in POTS?
- POTS patients may get relief from blood pressure drug, early study hints